Derivatives of polyhydroxy compounds
US-9796659-B2 · Oct 24, 2017 · US
US9394238B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9394238-B2 |
| Application number | US-201414521700-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 23, 2014 |
| Priority date | Jul 21, 2010 |
| Publication date | Jul 19, 2016 |
| Grant date | Jul 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a method for the production of L-carnitine, wherein a β-lactone, which is a 4-(halomethyl)oxetane-2-one, is converted into carnitine with trimethylamine (TMA), wherein the β-lactone is not subjected to a basic hydrolysis step before being contacted with the trimethylamine. The invention also relates to a carnitine having a unique impurity profile.
Opening claim text (preview).
The invention claimed is: 1. A process for the production of L-carnitine, wherein a β-lactone, which is a 4-(halomethyl)oxetane-2-one, is converted into carnitine with trimethylamine (TMA), wherein the β-lactone is not subjected to a hydrolysis step before being contacted with the trimethylamine. 2. The process of claim 1 , wherein a basic hydrolysis and addition of trimethylamine (TMA) are carried out in one process step. 3. The process of claim 1 , wherein the basic hydrolysis is carried out with a metal hydroxide, preferably sodium hydroxide. 4. The process of claim 3 , wherein the β-lactone is brought into contact with the metal hydroxide and the trimethylamine essentially at the same time. 5. The process of claim 3 , wherein the amount of the metal hydroxide is 1.1 to 1.6 equivalents, preferably 1.2 to 1.4 equivalents, based on the initial amount of β-lactone. 6. The process of claim 3 , wherein the β-lactone is brought into contact with an aqueous solution comprising the metal hydroxide and the trimethylamine. 7. The process of claim 3 , wherein a solution of the β-lactone in an organic solvent is provided and mixed with an aqueous solution comprising TMA and a metal hydroxide. 8. The process of claim 1 , wherein the reaction is carried out at a temperature between −20° C. and 40° C., preferably between 0° C. and 25° C. 9. The process of claim 1 , wherein basic hydrolysis is mediated by the TMA and no additional base is added for basic hydrolysis. 10. The process of claim 1 , wherein the β-lactone is a chiral β-lactone and the carnitine is L-carnitine. 11. The process of claim 1 , comprising an additional step, in which the L-carnitine is purified via a combination of electrodialysis and subsequent recrystallization. 12. The process of claim 1 , comprising a preceding step, in which the β-lactone is obtained in a [2+2] cycloaddition of ketene with an aldehyde X—CH 2 —CHO, wherein X is selected from Cl, Br and I, in the presence of a chiral catalyst. 13. The process of claim 12 , wherein the chiral catalyst is a Lewis acid-Lewis base bifunctional metal catalyst or an organic phosphine catalyst. 14. L-carnitine, characterized by having an amount of hydroxycrotonic acid in the range of 0.5-0.1 wt-% or in the range of 0.5-0.005 wt-%. 15. The process of claim 4 , wherein the amount of the metal hydroxide is 1.1 to 1.6 equivalents, preferably 1.2 to 1.4 equivalents, based on the initial amount of β-lactone. 16. The process of claim 4 , wherein the β-lactone is brought into contact with an aqueous solution comprising the metal hydroxide and the trimethylamine. 17. The process of claim 5 , wherein the β-lactone is brought into contact with an aqueous solution comprising the metal hydroxide and the trimethylamine. 18. The process of claim 6 , wherein a solution of the β-lactone in an organic solvent is provided and mixed with an aqueous solution comprising TMA and a metal hydroxide. 19. The L-carnitine of claim 14 , obtainable by a process according to claim 11 .
the carbon skeleton being further substituted by oxygen atoms · CPC title
Separation; Purification · CPC title
Beta-lactones · CPC title
Crystallisation · CPC title
by reaction of ammonia or amines with acids containing functional groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.